# Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma

> clinical trial · VERIFIED · 2026-08-10

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04609046

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.